Presentation
6 March 2023 Combined OCT-NIRF imaging for esophageal cancer detection
Author Affiliations +
Proceedings Volume PC12371, Multimodal Biomedical Imaging XVIII; PC1237105 (2023) https://doi.org/10.1117/12.2649812
Event: SPIE BiOS, 2023, San Francisco, California, United States
Abstract
Esophageal cancer has a low survival rate, which is significantly improved through early detection, as well as monitoring of a common pre-cursor, Barrett’s esophagus. Optical Coherence Tomography is a low coherence interferometry technique which produces three-dimensional depth scans of tissues. OCT provides morphology but lacks in molecular specificity, and can thus be combined with targeted Near Infrared Fluorescence imaging. The viability of this dual-modality technique for use in detecting BE and esophageal cancer is assessed using topically and intravenously administered Bevacizumab in combination with an OCT-NIRF system, to produce ex vivo tissue scans, which are then histology matched.
Conference Presentation
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Tyla Danskin, Margherita Vaselli, and Johannes F. de Boer "Combined OCT-NIRF imaging for esophageal cancer detection", Proc. SPIE PC12371, Multimodal Biomedical Imaging XVIII, PC1237105 (6 March 2023); https://doi.org/10.1117/12.2649812
Advertisement
Advertisement
KEYWORDS
Optical coherence tomography

Cancer

Imaging systems

Luminescence

Endoscopy

Tissues

Esophagus

Back to Top